ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. Since 1923 ALK has been working to improve the quality of life for allergy patients by developing drugs that target the cause of allergy. ALK is the world leader in allergy immunotherapy - a unique treatment of the cause of allergies. The treatment induces a protective immune response that provides a sustained reduction of allergy symptoms and reduces the risk of developing asthma. ALK provides allergy immunotherapy products as injections, sublingual drops and sublingual tablets, which is the newest, best documented and most convenient treatment for patients. The portfolio of products also includes an adrenaline used to treat severe allergic reactions (anaphylactic shock). ALK invests annually approx. 20% of revenue in research that aims to develop new, evidence-based allergy immunotherapy. Research and development pipeline includes sublingual allergy immunoterapy tablets against ragweed, house dust mite and tree pollen allergy. ALK has signed partnership agreements with Merck and Torii Pharmaceutical, concerning the development, registration and commercialisation of tablets in Northern America and Japan. ALK has approx. 1,800 employees with subsidiaries, production facilities and distributors worldwide. The company headquarters is in Denmark and is listed on NASDAQ OMX Copenhagen (OMX: ALK B). In 2013 the turnover was more than DKK 2.2 billion (EURm 300).

ImVisioN GmbH provides research in intralymphatic immunotherapy. It is a biotechnology company which specializes the use of intralymphatic immunotherapy to develop treatments for major allergies. Its product, IVN201, is a MAT immunotherapeutic that targets cat dander allergy, a common allergy inadequately addressed by available therapeutic interventions. The company was founded in 2005 and is headquartered in Hanover, Germany.

ALK is a healthcare service provider. They offer products and services via a web shop to help people manage their allergies. It also provides treatment for respiratory allergies that works by treating the underlying cause of the allergy.

Omega Paw, Inc. is a Canadian private company that develops and manufactures dog supplies & cat products.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA.

Part of Celldex Therapeutics, Inc., Virus Research Institute, Inc. is an American company located in Cambridge, MA. The firm develops systems for the delivery of vaccines.

Wenzhou Xinlan Intelligent Technology Co., Ltd., established on 2018-12-13, Business scope includes smart products,Technology development in the field of electronics,technical consulting,Technical Services;Intelligent electronic control system engineering,Building integrated wiring engineering,Computer network system engineering construction,Install,maintain;Communication equipment sales,Install,repair(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of BioNTech SE, BioNTech RNA Pharmaceuticals GmbH is a company headquartered in Mainz, Germany, that develops immunotherapies to revolutionize the treatment of cancer and other diseases.

Bioventures LLC is an American private company located in Tulsa, OK, that develops pharmaceutical products. The firm was founded in 2004.

Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Hangzhou Aiyale Maternity & Baby Products Co., Ltd., established on 2019-09-05, Business scope includes sales(Including online sales):electronic product(Except for electronic publications),Daily necessities,pet supplies,cosmetic,knitted goods,Computer hardware and software and peripheral auxiliary equipment,Office Supplies,household appliances,furniture,Clothes, shoes,Green facilities,Wujinjiaodian,Audio equipment,Equipment,ceramics,lighting equipment,Jewelry,Toy,automobile parts,Elevators and accessories;technology development,technical consulting,Technical Services,technology transfer:network technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiamen Jixinde Group Co., Ltd., established on 2001-07-10, The scope of business includes the manufacture of wood processing machinery;Other unspecified manufacturing industries(Items not subject to permit approval);Design of robots and smart devices,research and development,Manufacturing and sales(Items not subject to permit approval);Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Other unspecified wholesale business(Does not include business items subject to permit approval);internet sales;Other unspecified retail trade(Items not subject to permit approval);software development;Information Technology Consulting Services;Other unspecified information technology service industry(Items not subject to permit approval);other internet services(Items not subject to permit approval);Other unlisted business service industry(Items not subject to permit approval).

Sinogene uses a solution called somatic cell nuclear transfer for pet cloning. Sinogene believes that the advancement of breeding and genetics will be beneficial to animal genetic research. The company's team includes scientists, doctors, and veterinary specialists.